Science and Research

RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment

In this multi-center, randomized, open pilot study the therapeutic effect of two prarallel groups treated with either Riciguat or Macitentan shall be determined by evaluating the change in systolic and diastolic RV function within 12 weeks after first drug intake in order to plan a larger Phase II study.The method used to determine the RV function will be the "Conductance Method".

Study details
Study-ID: NCT03362047, 2015-002835-17
DZL Disease Area: PH
DZL Disease Area: PH
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL recruiting center, DZL Investigator Initiated Trial
DZL Role: DZL recruiting center, DZL Investigator Initiated Trial
Funding: DZL
Funding: DZL
DZL Participating Sites: UGMLC
DZL Participating Sites: UGMLC
Start Date: 01.03.2018
Completion Date: 14.08.2024
Status: Terminated
Status: Terminated
DZL recruiting center, DZL Investigator Initiated Trial
Link to Study


chevron-down